Showing results (1871-1880 of 2,210) with videos related to
Sort By:
Pageof 221
Drugs|November 1, 2021
Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)Jason Bacharach, Andrew Tatham, Gloria Ferguson, et al.ACS Chemical Biology|January 21, 2017
Mapping the Phosphorylation Pattern of Drosophila melanogaster RNA Polymerase II Carboxyl-Terminal Domain Using Ultraviolet Photodissociation Mass SpectrometryJoshua E Mayfield, Michelle R Robinson, Victoria C Cotham, et al.World Journal for Pediatric & Congenital Heart Surgery|December 12, 2013
Patient age at the Ross operation in children influences aortic root dimensions and aortic regurgitationJürgen Hörer, Jelena Kasnar-Samprec, Efstratios Charitos, et al.Neoplasia (New York, N.Y.)|December 2, 2011
Detection of somatic copy number alterations in cancer using targeted exome capture sequencingRobert J Lonigro, Catherine S Grasso, Dan R Robinson, et al.Annals of Internal Medicine|February 15, 1997
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trialJ P Lalezari, R J Stagg, B D Kuppermann, et al.Circulation. Cardiovascular Interventions|March 1, 2021
Optical Coherence Tomography Assessment in Patients Treated With Rotational Atherectomy Versus Modified Balloons: PREPARE-CALC OCTRayyan Hemetsberger, Tommaso Gori, Ralph Toelg, et al.Experimental Eye Research|September 20, 2005
A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonideMichael R Robinson, Susan S Lee, Hyuncheol Kim, et al.Retina (Philadelphia, Pa.)|June 14, 2006
Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administrationHyuncheol Kim, Karl G Csaky, Luisa Gravlin, et al.Journal of Alzheimer'S Disease : JAD|September 24, 2023
Associations Between Amyloid Burden, Hypoxemia, Sleep Architecture, and Cognition in Obstructive Sleep ApneaMarina G Cavuoto, Stephen R Robinson, Fergal J O'Donoghue, et al.Mabs|July 2, 2016
The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®Bishu Ganguly, Balaji Balasa, Lyubov Efros, et al.Pageof 221